BioMedInvest in CHF106m final close
Swiss life sciences firm BioMed Partners has closed its second fund, BioMedInvest II, with CHF106m (€73m) in commitments.
The new vehicle, which will invest in private early- to mid-stage companies in Germany, Switzerland and neighbouring European countries, is backed by...